Fat‐1 transgenic mice rich in endogenous omega‐3 fatty acids are protected from lipopolysaccharide‐induced cardiac dysfunction

Abstract Aims Cardiac malfunctions developing in result of sepsis are hard to treat so they eventually contribute to the increased mortality. Previous reports indicated for therapeutic potential of exogenous ω‐3 polyunsaturated fatty acids (PUFA) in sepsis, but potential benefits of this compound on...

Full description

Bibliographic Details
Main Authors: Shuai Mao, Huan Ma, Peipei Chen, Yubin Liang, Minzhou Zhang, Aleksander Hinek
Format: Article
Language:English
Published: Wiley 2021-06-01
Series:ESC Heart Failure
Subjects:
Online Access:https://doi.org/10.1002/ehf2.13262
_version_ 1797976424738455552
author Shuai Mao
Huan Ma
Peipei Chen
Yubin Liang
Minzhou Zhang
Aleksander Hinek
author_facet Shuai Mao
Huan Ma
Peipei Chen
Yubin Liang
Minzhou Zhang
Aleksander Hinek
author_sort Shuai Mao
collection DOAJ
description Abstract Aims Cardiac malfunctions developing in result of sepsis are hard to treat so they eventually contribute to the increased mortality. Previous reports indicated for therapeutic potential of exogenous ω‐3 polyunsaturated fatty acids (PUFA) in sepsis, but potential benefits of this compound on the malfunctional heart have not been explored yet. In the present study, we investigated whether the constantly elevated levels of endogenous ω‐3 PUFA in transgenic fat‐1 mice would alleviate the lipopolysaccharide (LPS)‐induced cardiac failure and death. Methods and results After both wild type (WT) and transgenic fat‐1 mice were challenged with LPS, a Kaplan–Meier curve and echocardiography were performed to evaluate the survival rates and cardiac function. Proteomics analysis, RT‐PCR, western blotting, immune‐histochemistry, and transmission electron microscopy were further performed to investigate the underlying mechanisms. Results showed that transgenic fat‐1 mice exhibited the significantly lower mortality after LPS challenge as compared with their WT counterparts (30% vs. 42.5%, P < 0.05). LPS injection consistently impaired the left ventricular contractile function and caused the cardiac injury in the wild type mice, but not significantly affected the fat‐1 mice (P < 0.05). Proteomic analyses, ELISA, and immunohistochemistry further revealed that myocardium of the LPS‐challenged fat‐1 mice demonstrated the significantly lower levels of pro‐inflammatory markers and ROS than WT mice. Meaningfully, the LPS‐treated fat‐1 mice also demonstrated a significantly higher levels of LC3 II/I and Atg7 expressions than the LPS‐treated WT mice (P < 0.05), as well as displayed a selectively increased levels of peroxisome proliferator‐activated receptor (PPAR) γ and sirtuin (Sirt)‐1 expression, associated with a parallel decrease in NFκB activation. Conclusions The fat‐1 mice were protected from the detrimental LPS‐induced inflammation and oxidative stress, and exhibited enhancement of the autophagic flux activities, associating with the increased Sirt‐1 and PPARγ signals.
first_indexed 2024-04-11T04:51:51Z
format Article
id doaj.art-1f1b7fc26ec84e17b5367334bd70fce5
institution Directory Open Access Journal
issn 2055-5822
language English
last_indexed 2024-04-11T04:51:51Z
publishDate 2021-06-01
publisher Wiley
record_format Article
series ESC Heart Failure
spelling doaj.art-1f1b7fc26ec84e17b5367334bd70fce52022-12-27T03:53:06ZengWileyESC Heart Failure2055-58222021-06-01831966197810.1002/ehf2.13262Fat‐1 transgenic mice rich in endogenous omega‐3 fatty acids are protected from lipopolysaccharide‐induced cardiac dysfunctionShuai Mao0Huan Ma1Peipei Chen2Yubin Liang3Minzhou Zhang4Aleksander Hinek5State Key Laboratory of Dampness Syndrome of Chinese Medicine, The Second Affiliated Hospital Guangzhou University of Chinese Medicine Guangzhou ChinaHeart Center Guangdong Provincial General Hospital Guangzhou ChinaState Key Laboratory of Dampness Syndrome of Chinese Medicine, The Second Affiliated Hospital Guangzhou University of Chinese Medicine Guangzhou ChinaState Key Laboratory of Dampness Syndrome of Chinese Medicine, The Second Affiliated Hospital Guangzhou University of Chinese Medicine Guangzhou ChinaState Key Laboratory of Dampness Syndrome of Chinese Medicine, The Second Affiliated Hospital Guangzhou University of Chinese Medicine Guangzhou ChinaTranslational Medicine, Hospital for Sick Children Toronto Ontario CanadaAbstract Aims Cardiac malfunctions developing in result of sepsis are hard to treat so they eventually contribute to the increased mortality. Previous reports indicated for therapeutic potential of exogenous ω‐3 polyunsaturated fatty acids (PUFA) in sepsis, but potential benefits of this compound on the malfunctional heart have not been explored yet. In the present study, we investigated whether the constantly elevated levels of endogenous ω‐3 PUFA in transgenic fat‐1 mice would alleviate the lipopolysaccharide (LPS)‐induced cardiac failure and death. Methods and results After both wild type (WT) and transgenic fat‐1 mice were challenged with LPS, a Kaplan–Meier curve and echocardiography were performed to evaluate the survival rates and cardiac function. Proteomics analysis, RT‐PCR, western blotting, immune‐histochemistry, and transmission electron microscopy were further performed to investigate the underlying mechanisms. Results showed that transgenic fat‐1 mice exhibited the significantly lower mortality after LPS challenge as compared with their WT counterparts (30% vs. 42.5%, P < 0.05). LPS injection consistently impaired the left ventricular contractile function and caused the cardiac injury in the wild type mice, but not significantly affected the fat‐1 mice (P < 0.05). Proteomic analyses, ELISA, and immunohistochemistry further revealed that myocardium of the LPS‐challenged fat‐1 mice demonstrated the significantly lower levels of pro‐inflammatory markers and ROS than WT mice. Meaningfully, the LPS‐treated fat‐1 mice also demonstrated a significantly higher levels of LC3 II/I and Atg7 expressions than the LPS‐treated WT mice (P < 0.05), as well as displayed a selectively increased levels of peroxisome proliferator‐activated receptor (PPAR) γ and sirtuin (Sirt)‐1 expression, associated with a parallel decrease in NFκB activation. Conclusions The fat‐1 mice were protected from the detrimental LPS‐induced inflammation and oxidative stress, and exhibited enhancement of the autophagic flux activities, associating with the increased Sirt‐1 and PPARγ signals.https://doi.org/10.1002/ehf2.13262ω‐3 polyunsaturated fatty acidsSepsisCardiac dysfunctionAutophagy
spellingShingle Shuai Mao
Huan Ma
Peipei Chen
Yubin Liang
Minzhou Zhang
Aleksander Hinek
Fat‐1 transgenic mice rich in endogenous omega‐3 fatty acids are protected from lipopolysaccharide‐induced cardiac dysfunction
ESC Heart Failure
ω‐3 polyunsaturated fatty acids
Sepsis
Cardiac dysfunction
Autophagy
title Fat‐1 transgenic mice rich in endogenous omega‐3 fatty acids are protected from lipopolysaccharide‐induced cardiac dysfunction
title_full Fat‐1 transgenic mice rich in endogenous omega‐3 fatty acids are protected from lipopolysaccharide‐induced cardiac dysfunction
title_fullStr Fat‐1 transgenic mice rich in endogenous omega‐3 fatty acids are protected from lipopolysaccharide‐induced cardiac dysfunction
title_full_unstemmed Fat‐1 transgenic mice rich in endogenous omega‐3 fatty acids are protected from lipopolysaccharide‐induced cardiac dysfunction
title_short Fat‐1 transgenic mice rich in endogenous omega‐3 fatty acids are protected from lipopolysaccharide‐induced cardiac dysfunction
title_sort fat 1 transgenic mice rich in endogenous omega 3 fatty acids are protected from lipopolysaccharide induced cardiac dysfunction
topic ω‐3 polyunsaturated fatty acids
Sepsis
Cardiac dysfunction
Autophagy
url https://doi.org/10.1002/ehf2.13262
work_keys_str_mv AT shuaimao fat1transgenicmicerichinendogenousomega3fattyacidsareprotectedfromlipopolysaccharideinducedcardiacdysfunction
AT huanma fat1transgenicmicerichinendogenousomega3fattyacidsareprotectedfromlipopolysaccharideinducedcardiacdysfunction
AT peipeichen fat1transgenicmicerichinendogenousomega3fattyacidsareprotectedfromlipopolysaccharideinducedcardiacdysfunction
AT yubinliang fat1transgenicmicerichinendogenousomega3fattyacidsareprotectedfromlipopolysaccharideinducedcardiacdysfunction
AT minzhouzhang fat1transgenicmicerichinendogenousomega3fattyacidsareprotectedfromlipopolysaccharideinducedcardiacdysfunction
AT aleksanderhinek fat1transgenicmicerichinendogenousomega3fattyacidsareprotectedfromlipopolysaccharideinducedcardiacdysfunction